Immunofluorescence staining for cleaved caspase 3 revealed that the treatment with AP39 locally reduced the level of active caspase 3 in the neurons of the frontal cortex and the dorsal striatum of the animals subjected to focal cerebral ischemia (Figure 9). Here, CASP3 is linked to brain ischemia.